<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01613664</url>
  </required_header>
  <id_info>
    <org_study_id>PI11-PR-REGIMBEAU-2</org_study_id>
    <nct_id>NCT01613664</nct_id>
  </id_info>
  <brief_title>Efficiency of TISSEEL for Sleeve Gastrectomy Complications</brief_title>
  <acronym>TISSEEL</acronym>
  <official_title>Randomized Prospective Clinical Study Evaluating the Usefulness of Fibrin Glue (TISSEEL® KIT) to Prevent Gastric Fistula, Intra Abdominal Haemorrhage and Intra Abdominal Loco Regional Collections After Laparoscopic Sleeve Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laparoscopic Sleeve Gastrectomy has emerged over the last 20 years as a treatment of choice
      in the surgical management of patients with morbid obesity. However, this restrictive
      procedure is accompanied by outcomes such as gastric fistula (5%), postoperative hemorrhage
      (1%) and intra-abdominal loco regional collections (1%). At present, there is no sufficiently
      reliable technique to prevent these complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The hypothesis is the following : the use of fibrin glue (Tissucol ®) during Laparoscopic
      Sleeve Gastrectomy would reduce the incidence of complications (gastric fistula,
      intra-abdominal hemorrhage and intra-abdominal locoregional collection).

      The aim is to investigate whether the use of fibrin glue (Tissucol®) during Laparoscopic
      Sleeve Gastrectomy reduces the incidence of postoperative complications (gastric fistula,
      intra-abdominal hemorrhage and intra-abdominal locoregional collection)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>presence of post-operative complications</measure>
    <time_frame>post operative day 30</time_frame>
    <description>The primary endpoint corresponds to the presence of complications after laparoscopic sleeve gastrectomy during the follow up period. A complication is considered as &quot;present&quot; if at least one of the following three items is present:
Gastric fistula
Postoperative hemorrhage
intra-abdominal locoregional collection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The gastric fistula's rate</measure>
    <time_frame>post operative day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The postoperative hemorrhage's rate</measure>
    <time_frame>post-operative day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The intra-abdominal locoregional collection's rate</measure>
    <time_frame>post-operative day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the length of stay</measure>
    <time_frame>post-operative day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the rate of readmission</measure>
    <time_frame>post-operative day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the rate of reintervention</measure>
    <time_frame>post-operative day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the overall mortality at one month</measure>
    <time_frame>post-operative day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the specific mortality at one month</measure>
    <time_frame>post-operative day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the rate of postoperative morbidity</measure>
    <time_frame>postoperative day 30</time_frame>
    <description>the morbidity will be evaluated according to the clavien dindo classification</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>tisseel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>tisseel will be applied during the surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no tisseel</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>no tisseel will be applied during the surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tisseel</intervention_name>
    <description>The product will be given as a 2 mL bottle per patient, which will be spread along the staple line. If necessary, a second bottle of 2 mL is used. The precautions for use are described in the user manual.</description>
    <arm_group_label>tisseel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no tisseel</intervention_name>
    <description>the surgeon does not applied tissucol during the surgery</description>
    <arm_group_label>no tisseel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obesity requiring bariatric surgery (Laparoscopic Sleeve Gastrectomy) according to the
             Haute Autorité de Santé

          -  Patients younger than 60 years old

          -  BMI ≤ 60 kg/m2

          -  Surgery accepted by an Obesity-related specific committee

          -  Patient with social protection

        Exclusion Criteria:

          -  Previous bariatric or gastric surgery

          -  BMI &gt; 60 kg/m2

          -  Under 18 years old

          -  Allergy to Tissucol®

          -  peroperative fistula

          -  Consent not signed

          -  Incapable of giving his opinion

          -  Pregnancy or breast-feeding

          -  Contraindication to surgery

          -  ASA classification IV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Marc REGIMBEAU, MD,phD</last_name>
    <role>Principal Investigator</role>
    <affiliation>chu amiens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>michel scotte, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>chu Rouen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Marc REGIMBEAU, MD, phD</last_name>
    <phone>+33322667928</phone>
    <email>regimbeau.jean-marc@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>North Universitary Hospital</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jean-Marc REGIMBEAU, MD, phD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charles Nicolle Universitary Hospital</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>michel scotte, MD phD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Pequignot A, Fuks D, Verhaeghe P, Dhahri A, Brehant O, Bartoli E, Delcenserie R, Yzet T, Regimbeau JM. Is there a place for pigtail drains in the management of gastric leaks after laparoscopic sleeve gastrectomy? Obes Surg. 2012 May;22(5):712-20. doi: 10.1007/s11695-012-0597-0.</citation>
    <PMID>22328096</PMID>
  </reference>
  <reference>
    <citation>Péquignot A, Dhahria A, Mensah E, Verhaeghe P, Badaoui R, Sabbagh C, Regimbeau JM. Stapling and Section of the Nasogastric Tube during Sleeve Gastrectomy: How to Prevent and Recover? Case Rep Gastroenterol. 2011;5(2):350-4. doi: 10.1159/000329706. Epub 2011 Jul 6.</citation>
    <PMID>21769286</PMID>
  </reference>
  <reference>
    <citation>Dhahri A, Verhaeghe P, Hajji H, Fuks D, Badaoui R, Deguines JB, Regimbeau JM. Sleeve gastrectomy: technique and results. J Visc Surg. 2010 Oct;147(5 Suppl):e39-46. doi: 10.1016/j.jviscsurg.2010.08.016.</citation>
    <PMID>20971049</PMID>
  </reference>
  <reference>
    <citation>Sabbagh C, Verhaeghe P, Dhahri A, Brehant O, Fuks D, Badaoui R, Regimbeau JM. Two-year results on morbidity, weight loss and quality of life of sleeve gastrectomy as first procedure, sleeve gastrectomy after failure of gastric banding and gastric banding. Obes Surg. 2010 Jun;20(6):679-84. doi: 10.1007/s11695-009-0007-4. Epub 2009 Nov 10.</citation>
    <PMID>19902316</PMID>
  </reference>
  <reference>
    <citation>Fuks D, Verhaeghe P, Brehant O, Sabbagh C, Dumont F, Riboulot M, Delcenserie R, Regimbeau JM. Results of laparoscopic sleeve gastrectomy: a prospective study in 135 patients with morbid obesity. Surgery. 2009 Jan;145(1):106-13. doi: 10.1016/j.surg.2008.07.013. Epub 2008 Sep 30.</citation>
    <PMID>19081482</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2012</study_first_submitted>
  <study_first_submitted_qc>June 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2012</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>surgical management</keyword>
  <keyword>sleeve gastrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrin Tissue Adhesive</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

